21 CFR Part 524
23 sections.
- § 524.86Amitraz
- § 524.154Bacitracin, neomycin, and polymyxin B ophthalmic ointment
- § 524.155Bacitracin, neomycin, polymyxin B, and hydrocortisone ophthalmic ointment
- § 524.230Buprenorphine
- § 524.390Chloramphenicol ophthalmic ointment
- § 524.402Chlorhexidine
- § 524.450Clotrimazole
- § 524.463Copper naphthenate
- § 524.575Cyclosporine ophthalmic ointment
- § 524.590Diclofenac
- § 524.660Dimethyl sulfoxide
- § 524.770Doramectin
- § 524.775Emodepside and praziquantel
- § 524.802Enrofloxacin and silver sulfadiazine otic emulsion
- § 524.814Eprinomectin
- § 524.815Eprinomectin and praziquantel
- § 524.838Esafoxolaner, eprinomectin, and praziquantel
- § 524.900Famphur
- § 524.920Fenthion
- § 524.955Florfenicol, terbinafine, and betamethasone acetate otic gel
- § 524.957Florfenicol, terbinafine, and mometasone otic solution
- § 524.960Flumethasone, neomycin, and polymyxin B ophthalmic solution
- § 524.970Flunixin
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.